WeVote

Bill

Bill

HB 2387

Relating to psilocybin; and declaring an emergency.

2025 Regular Session Introduced by Dacia Grayber and 2 co-sponsors

Oregon's HB 2387 establishes regulatory framework for psilocybin use, effective immediately, governing therapy programs and clinical implementation with emergency authority.

Chapter 147, (2025 Laws): Effective date May 22, 2025.
0
WeVote Research Nonpartisan
Bill Summary · HB 2387

Legislative bill overview

HB 2387 is an Oregon law that regulates psilocybin, a controlled substance found in certain mushrooms with psychoactive properties. The bill became effective May 22, 2025, after passing through the legislature and receiving the governor's signature. The "emergency" declaration indicates the sponsors viewed this as requiring immediate implementation rather than waiting for standard effective dates.

Why is this important

Psilocybin regulation affects Oregon's emerging psychedelic therapy sector, particularly given Oregon's 2020 voter approval of psilocybin-assisted therapy programs. This law likely establishes operational frameworks, licensing requirements, or safety protocols that determine how psilocybin services function legally in the state. The timing and emergency status suggest urgency around implementation of existing voter-approved programs or addressing regulatory gaps.

Potential points of contention

  • Scope of regulation: Whether the bill expands or restricts access to psilocybin-assisted therapy, potentially affecting patients seeking treatment for depression, PTSD, or end-of-life anxiety
  • Implementation costs: Emergency provisions may bypass normal budget review, raising questions about funding sources for new regulatory agencies or oversight mechanisms
  • Decriminalization vs. medicalization: Unclear whether provisions affect criminal penalties for personal possession versus regulated clinical use, affecting different constituencies differently

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.